SATPP

official impact factor 1.58

Open Access Research

A success story: HIV prevention for injection drug users in Rhode Island

Curt G Beckwith1*, Carla C Moreira1, Hesham M Aboshady1,2, Nickolas Zaller1, Josiah D Rich1 and Timothy P Flanigan1

Author Affiliations

1 Brown Medical School, Department of Medicine, The Miriam Hospital, 164 Summit Ave, Providence, Rhode Island 02906, USA

2 Rhode Island Department of Health, 3 Capitol Hill, Providence, Rhode Island, 02908, USA

For all author emails, please log on.

Substance Abuse Treatment, Prevention, and Policy 2006, 1:34 doi:10.1186/1747-597X-1-34

Published: 4 December 2006

Abstract

Background

New HIV diagnoses related to injection drug use (IDU) have declined in the United States. Access to clean syringes and decreasing HIV transmission among injection drug users have been HIV prevention priorities of the Rhode Island (RI) HIV community. To examine trends in IDU-related new HIV diagnoses in RI, we performed a retrospective analysis of new HIV diagnoses according to HIV risk factor from 1990–2003.

Results

There has been an 80% absolute reduction in IDU-related new HIV diagnoses in RI coincident with IDU-specific prevention efforts.

Conclusion

There has been a greater decline in IDU-related new HIV diagnoses in Rhode Island compared to national data reported by the Centers for Disease Control and Prevention. We hypothesize that this dramatic decline in Rhode Island is related to extensive HIV prevention efforts targeting IDUs. Further research is needed to examine the impact of specific HIV prevention interventions for injection drug users.